Work

Phase (ph) 3 study of eribulin (ERI) vs dacarbazine (DTIC) in leiomyosarcoma (LMS) and liposarcoma (LPS) patients (pts)

Year: 2016

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdw519

Authors: Patrick Schöffski, Edwin Choy, Axel Le Cesne, Veridiana Camargo, Sebastian Bauer, Sun Young Rha, Jean-Yves Blay, David R D'Adamo, Matthew Guo, Robert G Maki

Institutions: Universitair Ziekenhuis Leuven, Massachusetts General Hospital, Institut Gustave Roussy, Fondation Gustave Roussy, Hospital Sírio-Libanês, Severance Hospital, Centre Léon Bérard, Eisai (United States), Mount Sinai Medical Center, Tisch Cancer Institute

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2588550515

FWCI:

Cites:

Cited by: 1

Related to: 10